License U of T Technologies

Who is this for?

Industry and other parties interested in licensing or otherwise using University of Toronto (U of T) technologies or working with spinoff companies based on U of T intellectual property.

What do I need before I can begin?

No information is required to begin. If you have questions regarding licensing University of Toronto (U of T) technologies or working with our spinoff companies, please reach out to the Innovations & Partnerships Office: Director, Innovations at 416-946-5515.

Technology Licensing & Startup Opportunities

The University of Toronto (U of T) is a global leader in turning research into products, services, companies and jobs. The Innovations & Partnerships Office (IPO) is your one-stop-shop to license these technologies or work with spinoff companies based on U of T intellectual property (IP). IPO’s team of technology transfer professionals make the process as quick and easy as possible.

Use the Technology Explorer below to discover market-ready innovations and companies based on U of T IP or contact us to find custom solutions.

Deep Tech Download Newsletter

In the last 5 years, companies emerging from U of T Research have secured more than $1.5 billion in investment and capital. We're #1 in Canada for research-based startups and our ecosystem is among the top 10 university-managed incubators in the world.

Sign up for Deep Tech Download, our quarterly newsletter that features active investment opportunities and the latest on these research-based companies.

Technology Explorer

Technology Keywords
Detection of Pathogens using Electrochemical Sensing Pathogen , Bacteria , Biosensor , Sensors & Instrumentation , Water , Contamination , Environment 
Probiotics to Prevent Dental Cavities Probiotic , Cell , Bacteria , Dental , Cavities , Carries , Aligner , Therapeutics , Mouthwash , Orthodontic , Peptide , Plaque 
Nanoconstructs for Diagnosis and Treatment of Alzheimer’s Disease Alzheimer's disease , Neurological Disorders , Dementia , Therapeutics , Diagnostics , Theranostic , Nanoparticle , Biomedical Imaging , MRI , Biomarkers , Amyloid plaque , Brain 
Genetically Engineered Proteins for Diagnosis and Treatment of Crohn’s Disease Crohn's disease , IBD , Inflammatory bowel disease , cytokine , Therapeutics , Diagnostics , Intestine , Immunology 
Micro-robotic Capsule for Drug Delivery and Microbiome Sampling Inflammatory bowel disease , IBD , Crohn's disease , Colitis , Microrobot , Gastrointestinal , Drug Delivery , Therapeutics , Biologics , Sampling 
Therapeutic Targeting of a Novel Gene Product in Inflammatory Bowel Disease Inflammatory bowel disease , IBD , Therapeutics , Small Molecules , Crohn's disease , Colitis 
Nasal Delivery of Highly Effective COVID-19 Vaccines using Helper-Dependent Adenoviral Vectors Virus , Covid-19 , SARS-COV-2 , vaccine , mRNA , adenovirus 
Protein Domains for Controlling Gene Expression CRISPR , gene therapy , gene silencing , repression , gene activation , RNA , interference , KRAB 
Long-Term Cell Tracking using Magnetic Resonance Imaging MRI , Ferritin , Biomedical Imaging , 3D imaging , stem cells , Regenerative Medicine , clinical trials , cardiac , CNS , cells 
The Glucose Meter as a Detection System for Point-of-Care Gene Circuit Diagnostics Point-of-Care , Covid-19 , Diagnostics , Molecular Detection , Synthetic Biology , SARS-COV-2 , Cell Free , Protein Syntheis , Glucose Meter , PCR , Typhoid , Covid-19 , Reporter Gene , Virus , Bacteria , Ag Tech , Agriculture , Food Safety , Animal Health 


  • Market U of T technologies to industry
  • Support the development of startup companies
  • Negotiate license agreements with interested companies
  • Assist in finding partners and funding to support proof-of-concept and commercialization
  • Support long-term relationships with strategic partners that help develop early-stage discoveries into market-ready technologies and products

VPRI Contact


Jennifer Fraser

Director, Innovations
Innovations & Partnerships Office (IPO)
(416) 946-5515